SMS Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 1,488.04 million compared to INR 1,212.54 million a year ago. Revenue was INR 1,510.19 million compared to INR 1,233.83 million a year ago. Net income was INR 37.64 million compared to INR 89.63 million a year ago. Basic earnings per share from continuing operations was INR 0.44 compared to INR 1.07 a year ago.
For the nine months, sales was INR 3,726.26 million compared to INR 4,589.55 million a year ago. Revenue was INR 3,762.55 million compared to INR 4,637.27 million a year ago. Net loss was INR 105.7 million compared to net income of INR 558.11 million a year ago. Basic loss per share from continuing operations was INR 1.25 compared to basic earnings per share from continuing operations of INR 6.59 a year ago.